Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said it would acquire the company’s purification and filtration business for $4.
On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing up its biologics production business through a $4.1 billion acquisition. The buyout target is ...
Thermo Fisher called out that Solventum’s purification and filtration business is global, with a workforce of about 2,500 and sites across the Americas, Europe, the Middle East, Africa ...
Highly Complementary to Thermo Fisher’s Bioproduction Business and Strengthens Offering in the High Growth Bioprocessing Market Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results